You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.


Triple Negative x

patient and doctor holding hands

Triple-negative breast cancer (TNBC) gets its name from the fact that it is not driven by breast cancer’s three major molecular markers—estrogen receptor, progesterone receptor, and the HER2 oncogene—that classify breast cancer subtypes, making it untreatable with hormone- or HER2-directed therap

On Triple Negative Breast Cancer Day, the breast cancer community highlights a subtype of the disease defined by its aggressive nature and limited treatment options.

When a person is diagnosed with breast cancer, one of the first things to determine is what “subtype” of breast cancer it is.

Grid Reasercher Headshot - Ford James

BCRF sat down with Dr. James M. Ford to discuss his current work and interest in breast cancer research. Read on to learn more.